Company news

LivaNova PLC news in 2026

LivaNova PLC's news releases, calls and decks from 2026, newest first.

View company

LivaNova Reports Third-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

November 4, 2026

Neuromodulation Publishes Full 36-Month CORE-VNS Results Demonstrating Sustained and Increasing Benefits of LivaNova’s VNS Therapy for Drug-Resistant Epilepsy

October 23, 2026

LivaNova to Present at UBS, Wolfe, Stifel, and Jefferies Healthcare Conferences in November

October 21, 2026

LivaNova to Announce Third-Quarter 2026 Results

September 23, 2026

LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September

September 3, 2026

LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

August 5, 2026

LivaNova to Announce Second-Quarter 2026 Results

June 24, 2026

LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea

June 16, 2026

Jette Nygaard-Andersen Joins LivaNova Board as a New Director

June 11, 2026

LivaNova Appoints Anne Liddy as Chief Legal Officer

June 5, 2026

LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit

May 21, 2026

LivaNova to Present at Goldman Sachs Global Healthcare Conference in June

May 18, 2026

LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

May 5, 2026

Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea

April 20, 2026

LivaNova to Announce First-Quarter 2026 Results

March 24, 2026

LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea

March 18, 2026

LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance

February 24, 2026

Orrum Announces Strategic Partnership with LivaNova to Unite Intelligent Data with Innovative Perfusion Technology

February 20, 2026

LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results

January 19, 2026

Calls in 2026

Decks in 2026